Multimodal Management of Grade 1 and 2 Pancreatic Neuroendocrine Tumors

SIMPLE SUMMARY: As we are facing an increasing incidence of pancreatic neuroendocrine tumors (pNETs), it appears necessary to better classify this disease—and in 2017 the WHO classification introduced a new category of well differentiated grade 3 tumors. pNETs treatment requires some specific backgr...

Descripción completa

Detalles Bibliográficos
Autores principales: Marchese, Ugo, Gaillard, Martin, Pellat, Anna, Tzedakis, Stylianos, Abou Ali, Einas, Dohan, Anthony, Barat, Maxime, Soyer, Philippe, Fuks, David, Coriat, Romain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773540/
https://www.ncbi.nlm.nih.gov/pubmed/35053593
http://dx.doi.org/10.3390/cancers14020433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773540/
https://www.ncbi.nlm.nih.gov/pubmed/35053593
http://dx.doi.org/10.3390/cancers14020433

Ejemplares similares